Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +25.50p +1.58% 1,643.50p 1,645.50p 1,646.00p 1,649.50p 1,626.50p 1,626.50p 9,384,705 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,889.0 1,939.0 18.8 87.4 80,702.32

GlaxoSmithKline PLC Block listing Interim Review

12/05/2017 4:26pm

UK Regulatory (RNS & others)


GlaxoSmithKline (LSE:GSK)
Historical Stock Chart

1 Month : From Apr 2017 to May 2017

Click Here for more GlaxoSmithKline Charts.

TIDMGSK

RNS Number : 0510F

GlaxoSmithKline PLC

12 May 2017

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                            GlaxoSmithKline plc 
------------------------------------------------------------  -------------------------------------------------------- 
 Name of scheme:                                               GlaxoSmithKline Share Option Plan - Ordinary Shares 
------------------------------------------------------------  -------------------------------------------------------- 
 Period of return:                   From:                     1 November 2016            To:     30 April 2017 
----------------------------------  ------------------------  -------------------------  ------  --------------------- 
 Balance of unallotted securities under scheme(s) from 
  previous return:                                             3,530,802 
------------------------------------------------------------  -------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been 
  increased since the date of the last 
  return (if any increase has been applied for):               2,142,952(1) 
------------------------------------------------------------  -------------------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) 
  during period (see LR3.5.7G):                                1,569,653 
------------------------------------------------------------  -------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at 
  end of period:                                               4,104,101 
------------------------------------------------------------  -------------------------------------------------------- 
 (1) This figure includes an adjustment of +142,952 unallotted securities that were allotted 
  under the GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan but originally debited from 
  the balance for this Scheme. 
---------------------------------------------------------------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                                        GlaxoSmithKline plc 
------------------------------------------------------------------------  -------------------------------------------- 
 Name of scheme:                                                           GlaxoSmithKline Share Option Plan - ADS 
------------------------------------------------------------------------  -------------------------------------------- 
 Period of return:                               From:                     1 November 2016      To:    30 April 2017 
----------------------------------------------  ------------------------  -------------------  -----  ---------------- 
 Balance of unallotted securities under scheme(s) from previous return:    9,349,738 
------------------------------------------------------------------------  -------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been increased since 
  the date of the last 
  return (if any increase has been applied for):                           0 
------------------------------------------------------------------------  -------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) during 
  period (see LR3.5.7G):                                                   553,924 
------------------------------------------------------------------------  -------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at end of 
  period:                                                                  8,795,814 
------------------------------------------------------------------------  -------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                                          GlaxoSmithKline plc 
--------------------------------------------------------------------------  ------------------------------------------ 
 Name of scheme:                                                             Glaxo Wellcome UK Share Option Scheme 
--------------------------------------------------------------------------  ------------------------------------------ 
 Period of return:                                 From:                     1 November 2016     To:    30 April 2017 
------------------------------------------------  ------------------------  ------------------  -----  --------------- 
 Balance of unallotted securities under scheme(s) from previous return:      5,119,750 
--------------------------------------------------------------------------  ------------------------------------------ 
 Plus: The amount by which the block scheme(s) has been increased since 
  the date of the last 
  return (if any increase has been applied for):                             0 
--------------------------------------------------------------------------  ------------------------------------------ 
 Less: Number of securities issued/allotted under scheme(s) during period 
  (see LR3.5.7G):                                                            0 
--------------------------------------------------------------------------  ------------------------------------------ 
 Equals: Balance under scheme(s) not yet issued/allotted at end of period:   5,119,750 
--------------------------------------------------------------------------  ------------------------------------------ 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                               GlaxoSmithKline plc 
---------------------------------------------------------------  ----------------------------------------------------- 
 Name of scheme:                                                  Glaxo Wellcome International Share Option Scheme 
---------------------------------------------------------------  ----------------------------------------------------- 
 Period of return:                      From:                     1 November 2016           To:    30 April 2017 
-------------------------------------  ------------------------  ------------------------  -----  -------------------- 
 Balance of unallotted securities under scheme(s) from previous 
  return:                                                         13,267,156 
---------------------------------------------------------------  ----------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been 
  increased since the date of the last 
  return (if any increase has been applied for):                  0 
---------------------------------------------------------------  ----------------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) 
  during period (see LR3.5.7G):                                   0 
---------------------------------------------------------------  ----------------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at end 
  of period:                                                      13,267,156 
---------------------------------------------------------------  ----------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                                          GlaxoSmithKline plc 
--------------------------------------------------------------------------  ------------------------------------------ 
 Name of scheme:                                                             Glaxo Wellcome 1999 Share Option Plan 
--------------------------------------------------------------------------  ------------------------------------------ 
 Period of return:                                 From:                     1 November 2016     To:    30 April 2017 
------------------------------------------------  ------------------------  ------------------  -----  --------------- 
 Balance of unallotted securities under scheme(s) from previous return:      1,040,000 
--------------------------------------------------------------------------  ------------------------------------------ 
 Plus: The amount by which the block scheme(s) has been increased since 
  the date of the last 
  return (if any increase has been applied for):                             0 
--------------------------------------------------------------------------  ------------------------------------------ 
 Less: Number of securities issued/allotted under scheme(s) during period 
  (see LR3.5.7G):                                                            0 
--------------------------------------------------------------------------  ------------------------------------------ 
 Equals: Balance under scheme(s) not yet issued/allotted at end of period:   1,040,000 
--------------------------------------------------------------------------  ------------------------------------------ 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                    GlaxoSmithKline plc 
----------------------------------------------------  ---------------------------------------------------------------- 
 Name of scheme:                                       SmithKline Beecham 1989 Executive Share Option Plan - Approved 
                                                       - Ordinary Shares 
----------------------------------------------------  ---------------------------------------------------------------- 
 Period of return:           From:                     1 November 2016            To:        30 April 2017 
--------------------------  ------------------------  -------------------------  ---------  -------------------------- 
 Balance of unallotted securities under scheme(s) 
  from previous return:                                163,606 
----------------------------------------------------  ---------------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has 
  been increased since the date of the last 
  return (if any increase has been applied for):       0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Less: Number of securities issued/allotted under 
  scheme(s) during period (see LR3.5.7G):              0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet 
  issued/allotted at end of period:                    163,606 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                    GlaxoSmithKline plc 
----------------------------------------------------  ---------------------------------------------------------------- 
 Name of scheme:                                       SmithKline Beecham 1989 Executive Share Option Plan - 
                                                       Unapproved - ADS 
----------------------------------------------------  ---------------------------------------------------------------- 
 Period of return:           From:                     1 November 2016             To:       30 April 2017 
--------------------------  ------------------------  --------------------------  --------  -------------------------- 
 Balance of unallotted securities under scheme(s) 
  from previous return:                                275,420 
----------------------------------------------------  ---------------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has 
  been increased since the date of the last 
  return (if any increase has been applied for):       0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Less: Number of securities issued/allotted under 
  scheme(s) during period (see LR3.5.7G):              0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet 
  issued/allotted at end of period:                    275,420 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                    GlaxoSmithKline plc 
----------------------------------------------------  ---------------------------------------------------------------- 
 Name of scheme:                                       SmithKline Beecham 1989 Executive Share Option Plan - 
                                                       Unapproved - Ordinary 
----------------------------------------------------  ---------------------------------------------------------------- 
 Period of return:           From:                     1 November 2016            To:        30 April 2017 
--------------------------  ------------------------  -------------------------  ---------  -------------------------- 
 Balance of unallotted securities under scheme(s) 
  from previous return:                                100,000 
----------------------------------------------------  ---------------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has 
  been increased since the date of the last 
  return (if any increase has been applied for):       0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Less: Number of securities issued/allotted under 
  scheme(s) during period (see LR3.5.7G):              0 
----------------------------------------------------  ---------------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet 
  issued/allotted at end of period:                    100,000 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                   GlaxoSmithKline plc 
---------------------------------------------------  ----------------------------------------------------------------- 
 Name of scheme:                                      GlaxoSmithKline Savings Related Share Option Scheme 
---------------------------------------------------  ----------------------------------------------------------------- 
 Period of return:          From:                     1 November 2016            To:          30 April 2017 
-------------------------  ------------------------  -------------------------  -----------  ------------------------- 
 Balance of unallotted securities under scheme(s) 
  from previous return:                               2,742,626 
---------------------------------------------------  ----------------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has 
  been increased since the date of the last 
  return (if any increase has been applied for):      0 
---------------------------------------------------  ----------------------------------------------------------------- 
 Less: Number of securities issued/allotted under 
  scheme(s) during period (see LR3.5.7G):             0 
---------------------------------------------------  ----------------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet              2,742,626 (the GlaxoSmithKline Savings Related Share Option 
  issued/allotted at end of period:                   Scheme has now expired. The balance 
                                                      of 2,742,626 un-allotted shares under this Scheme has therefore 
                                                      lapsed) 
---------------------------------------------------  ----------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                                       GlaxoSmithKline plc 
-----------------------------------------------------------------------  --------------------------------------------- 
 Name of scheme:                                                          GlaxoSmithKline plc Share Save Plan 2012 
-----------------------------------------------------------------------  --------------------------------------------- 
 Period of return:                              From:                     1 November 2016       To:    30 April 2017 
---------------------------------------------  ------------------------  --------------------  -----  ---------------- 
 Balance of unallotted securities under scheme(s) from previous return:   239,107 
-----------------------------------------------------------------------  --------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been increased since 
  the date of the last 
  return (if any increase has been applied for):                          2,000,000 
-----------------------------------------------------------------------  --------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) during 
  period (see LR3.5.7G):                                                  603,782 
-----------------------------------------------------------------------  --------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at end of 
  period:                                                                 1,635,325 
-----------------------------------------------------------------------  --------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

BLOCK LISTING SIX MONTHLY RETURN

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 12 May 2017

 
 Name of applicant:                                            GlaxoSmithKline plc 
------------------------------------------------------------  -------------------------------------------------------- 
 Name of scheme:                                               GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan 
------------------------------------------------------------  -------------------------------------------------------- 
 Period of return:                   From:                     1 November 2016            To:     30 April 2017 
----------------------------------  ------------------------  -------------------------  ------  --------------------- 
 Balance of unallotted securities under scheme(s) from 
  previous return:                                             0 
------------------------------------------------------------  -------------------------------------------------------- 
 Plus: The amount by which the block scheme(s) has been 
  increased since the date of the last 
  return (if any increase has been applied for):               600,000 
------------------------------------------------------------  -------------------------------------------------------- 
 Less: Number of securities issued/allotted under scheme(s) 
  during period (see LR3.5.7G):                                399,929(1) 
------------------------------------------------------------  -------------------------------------------------------- 
 Equals: Balance under scheme(s) not yet issued/allotted at 
  end of period:                                               200,071 
------------------------------------------------------------  -------------------------------------------------------- 
 (1) This figure includes an adjustment of +142,952 allotted securities that were allotted 
  under this Scheme but originally debited from the balance for the block listing under the 
  GlaxoSmithKline Share Option Plan - Ordinary Shares. 
---------------------------------------------------------------------------------------------------------------------- 
 
 
 
 Name of contact:                Victoria Whyte 
------------------------------  --------------- 
 Telephone number of contact:    020 8047 5000 
------------------------------  --------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

BLRZMGMKKZZGNZM

(END) Dow Jones Newswires

May 12, 2017 11:26 ET (15:26 GMT)

1 Year GlaxoSmithKline Chart

1 Year GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart

1 Month GlaxoSmithKline Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V:gb D:20170530 05:35:49